跳至主要内容
临床试验/ISRCTN12911644
ISRCTN12911644已完成Unknown

A pilot clinical trial to test the acceptability and feasibility of different doses of oral iron supplementation to prevent maternal anaemia - PANDA-Dose Study

HS Blood and Transplant0 个研究点目标入组 300 人开始时间: 2023年4月27日最近更新:
适应症

试验速览

阶段
Unknown
状态
已完成
发起方
入组人数
300

研究概览

简要总结

2024 Results article in https://pubmed.ncbi.nlm.nih.gov/39208353/ (added 02/09/2024)

研究设计

研究类型
Interventional

入排标准

性别
Female

入选标准

  • 1. Healthy non-anaemic pregnant women of all parities (haemoglobin concentration (Hb) > = 110 g/l) at booking or screening.
  • 2. 13 weeks + 6 days gestation or less
  • 3. Age 18 and above
  • 4. Able to give informed consent and willing to fulfil trial requirements

排除标准

  • Women with the following conditions will be excluded:
  • 1. Known haemoglobinopathies
  • 2. Anaemia of any type, defined by BSH guidelines
  • 3. Severe gastrointestinal disease, affecting tolerability of oral iron
  • 4. Allergies to iron
  • 5. Multiple pregnancies, given the higher iron demands
  • 6. Known haemochromatosis
  • 7. Recent red cell transfusion, within 1 month

研究者

发起方
HS Blood and Transplant

相似试验

A clinical trial to find out the optimal oral iron... | 临床试验